Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026)
Glaukos (GKOS) reported Total Non-Current Liabilities of $192.9 million for Q1 2026, up 6.62% year-over-year from $180.9 million in Q1 2025, and down 6.17% quarter-over-quarter from $205.6 million in Q4 2025.
Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Total Non-Current Liabilities data on file, last reported at $192.9 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $192.9 million, up 6.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.9 million (up 6.62% YoY), and the FY2025 annual result was $205.6 million, up 10.86% from the prior year.
- Total Non-Current Liabilities slipped to $192.9 million in Q1 2026 per GKOS's latest filing, from $205.6 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $482.6 million in Q1 2024 and troughed at $180.9 million in Q1 2025.
- A 5-year average of $338.5 million and a median of $445.2 million in 2022 frame the typical range for Total Non-Current Liabilities.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 10.86% in 2025 and fell as far as 62.51% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $462.1 million in 2022, then gained by 0.61% to $464.9 million in 2023, then tumbled by 60.11% to $185.5 million in 2024, then advanced by 10.86% to $205.6 million in 2025, then slipped by 6.17% to $192.9 million in 2026.
- Business Quant data shows GKOS's Total Non-Current Liabilities at $192.9 million in Q1 2026, $205.6 million in Q4 2025, and $198.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | 192.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.91 Mn |
| Dec 31, 2025 | 205.59 Mn |
| Sep 30, 2025 | 198.75 Mn |
| Jun 30, 2025 | 191.07 Mn |
| Mar 31, 2025 | 180.93 Mn |
| Dec 31, 2024 | 185.45 Mn |
| Sep 30, 2024 | 235.95 Mn |
| Jun 30, 2024 | 233.84 Mn |
| Mar 31, 2024 | 482.61 Mn |
| Dec 31, 2023 | 464.90 Mn |
| Sep 30, 2023 | 458.18 Mn |
| Jun 30, 2023 | 455.02 Mn |
| Mar 31, 2023 | 452.89 Mn |
| Dec 31, 2022 | 462.10 Mn |
| Sep 30, 2022 | 450.42 Mn |
| Jun 30, 2022 | 459.35 Mn |
| Mar 31, 2022 | 445.18 Mn |
| Dec 31, 2021 | 453.05 Mn |
| Sep 30, 2021 | 454.10 Mn |
| Jun 30, 2021 | 450.82 Mn |